Edap Tms (NASDAQ:EDAP) Share Price Passes Above 200 Day Moving Average – Time to Sell?

Edap Tms S.A. (NASDAQ:EDAP) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.39 and traded as high as $4.21. Edap Tms shares last traded at $4.08, with a volume of 61,452 shares changing hands.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. Jefferies Financial Group reiterated a “hold” rating and set a $2.00 target price on shares of Edap Tms in a research report on Thursday, November 6th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Edap Tms in a report on Monday, December 29th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $8.50.

Edap Tms Stock Performance

The firm has a fifty day simple moving average of $3.14 and a 200-day simple moving average of $2.39. The company has a current ratio of 1.41, a quick ratio of 0.97 and a debt-to-equity ratio of 0.04. The stock has a market cap of $152.55 million, a price-to-earnings ratio of -7.16 and a beta of -0.26.

Edap Tms (NASDAQ:EDAP) last released its earnings results on Thursday, November 6th. The medical equipment provider reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.26) by $0.11. The company had revenue of $16.29 million during the quarter, compared to analysts’ expectations of $15.05 million. Edap Tms had a negative return on equity of 61.60% and a negative net margin of 30.95%. Analysts forecast that Edap Tms S.A. will post -0.6 EPS for the current fiscal year.

Institutional Trading of Edap Tms

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Sage Mountain Advisors LLC bought a new position in shares of Edap Tms in the 2nd quarter valued at about $165,000. Simplicity Wealth LLC bought a new stake in shares of Edap Tms during the second quarter worth approximately $54,000. Finally, Financial Planning Navigators CORP acquired a new position in Edap Tms in the fourth quarter valued at approximately $33,000. 62.74% of the stock is owned by institutional investors.

Edap Tms Company Profile

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.